AstraZeneca halts £200m research investment in Cambridge
The British drugmaker shelved a separate £450m ($612m) investment in a vaccine manufacturing plant in northern England, earlier this year.
15 September 2025
15 September 2025
The British drugmaker shelved a separate £450m ($612m) investment in a vaccine manufacturing plant in northern England, earlier this year.
LB Pharmaceuticals’ public listing comes amid a dry spell for biotech IPOs despite a flurry of activity early in 2025.
FDA chief Martin Makary said the agency will now ‘proactively monitor’ pharma companies for advertising law breaches.
The sodium oxybate oral solution is prescribed for managing cataplexy and excessive daytime sleepiness (EDS) in individuals with narcolepsy.
The healthcare editorial team unpicks several key trials and trends from this year's ESC Congress.
AbbVie has signed deals with Rinvoq generic hopefuls as it extends protection for one of its prized assets until 2037.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.